Efficacy of misoprostol in the treatment of tinnitus in patients with diabetes and/or hypertension

Auris Nasus Larynx

Volumn 31, Issue 3, 2004, Pages 226-232

  Akkuzu, Babur ^a   Yilmaz, Ismail ^a   Cakmak, Ozcan ^a   Ozluoglu, Levent N ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Diabet; Hypertension; Misoprostol; Tinnitus

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE; MISOPROSTOL; PLACEBO; PROSTAGLANDIN E1 DERIVATIVE;

ADULT; AGED; ANOREXIA; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EXPERIENCE; FEMALE; HEALTH CENTER; HUMAN; HYPERTENSION; LOUDNESS; MALE; NAUSEA; OBSERVATION; PATIENT REFERRAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SYMPTOM; TABLET; TINNITUS;

ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MISOPROSTOL; SEVERITY OF ILLNESS INDEX; TINNITUS;

EID: 4544303515     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2004.03.005     Document Type: Conference Paper

References (26)

1. Abrams WB, Beers MH, Berkow R, editors. The Merck Manual of Geriatrics, 2nd ed. Whitehouse Station, NJ: Merck & Co., Inc.; 1995. p. 454, 1001.
2. Briner W., House J., O'Leary M. Synthetic prostaglandin E1 misoprostol as a treatment for tinnitus. Arch. Otolaryngol. Head Neck Surg. 119:1993;652-654
3. Bobbin R., Thompson M. Effects of putative transmitters on afferent cochlear transmission. Ann. Otol. 87:1987;185-190
4. Cazevieille C., Muller A., Meynier F., Dutrait N., Bonne C. Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem. Int. 24:1994;395-398
5. Crinnion C.L., McCart G.M. Misoprostol for tinnitus. Ann. Pharmacother. 29:1995;782-784
6. Degoute C., Preckel M., Dubreuil C., Banssillon V., Duclaux R. Sympathetic nerve regulation of cochlear blood flow during increases in blood pressure in humans. Eur. J. Appl. Physiol. 75:1997;326-332
7. Dobie R.A., Skai C.S., Sullivan M.D., Katon W.J., Russo J. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction benefit. Am. J. Otol. 14:1993;18-23
8. Donald M.W., Bird C.E., Lawson J.S., Letemendia F.J., Monga T.N., Surridge D.H., et al. Delayed auditory brainstem responses in diabetes mellitus. J. Neurol. Neurosurg. Psychol. 44:1981;641-644
9. Escoubet B., Amsallem P., Ferrary E., Tran Ba Huy P. Prostaglandin synthesis by the cochlea of the guinea pig. Influence of aspirin, gentamycin, and acoustic stimulation. Prostaglandins. 29:1985;589-599
10. Fowler P.D., Jones N.S. Diabetes and hearing loss. Clin. Otolaryngol. 24:1999;3-8
11. Gates G.A., Cobb J.L., D'Agostino R.B., Wolf P.A. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch. Otolaryngol. Head Neck Surg. 119:1993;156-161
12. Hoke M., Pantev C., Lütkenhöner B., Lehnertz K. Auditory cortical basis of tinnitus. Acta. Otolaryngol. (Stockh.). 491(suppl):1991;176- 182
13. Jastreboff PJ, Gray WC, Mattox DE. Tinnitus and hyperacusis. In: Cummings CW, Frederickson JM, Harker LA, Krause CJ, Richardson M, Schuller DE, Richardson MA, ediors. Otolaryngology Head and Neck Surgery, 3rd ed. St.Louis: Mosby-Year Book; 1998. p. 3198-222.
14. Karetova D., Bultas J., Vondracek V., Aschermann M. Alprostadil: modes of actions in peripheral arterial occlusive disease. Am. J. Ther. 4:1997;359-363
15. Kobayashi K., Arakawa T., Higuchi K., Nakamura H. Gastric cytoprotection by ornoprostil, a PGE1 analogue, in human subjects. J. Clin. Gastroenterol. 13(Suppl. 1):1991;32-36
16. Markova M. The cochleovestibular syndrome in hypertension. Cesk. Otolaryngol. 39:1990;89-97
17. Marullo T. Contribution a l'etude des hypoacousies perceptives du diabete sucre. Rev. Laryngol. 95:1975;253-271
18. Matsuda K., Komune S., Tono T., Yamasaki M., Haruta A., Kato E. A role of glutamate in drug-induced ototoxicity: in vivo microdialysis study combined with on-line enzyme fluorometric detection of glutamate in the guinea pig cochlea. Brain Res. 852:2000;492-495
19. Meyerhoff WL, Cooper JC. Tinnitus. In: Paparella MM, Shumrick DA, Gluckman JL, editors. Otolaryngology, 3rd ed. Philadelphia: WB Saunders; 1991. p. 1169-79.
20. Mosnier I., Teixeira M., Loiseau A., Fernandes I., Sterkers O., Amiel C., et al. Effect of acute and chronic hypertension on the labyrinthine barriers in rat. Hear Res. 151:2001;227-236
21. Parving A., Elberling C., Balle V., Parbo J., Dejgaard A., Parving H.H. Hearing disorders in patients with insulin-dependent diabetes mellitus. Audiology. 29:1990;113-121
22. Sugawara Y., Kubota K., Ogura T., Esumi H., Inoue K., Takayama T., et al. Protective effect of prostaglandin E1 against ischemia/reperfusion-induced liver injury: results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy. J. Hepatol. 29:1998;969-976
23. Tachibana M., Yamamichi I., Nakae S., Hirasugi Y., Machino M., Mizukoshi O. The site of involvement of hypertension within the cochlea. Acta Otolaryngol. (Stockh.). 97:1984;257-265
24. Uemura K., Nakashima M. Effects of prostaglandin E1 on the rat inner ear microvascular thrombosis. Gen. Pharmacol. 28:1997;221-224
25. Verma A., Bisht M.S., Ahuja C.K. Involvement of the central nervous system in diabetes mellitus. J. Neurol. Neurosurg. Psychol. 47:1984;414-416
26. Wackym P.A., Linthicum F.H. Diabetes mellitus and hearing loss: clinical and histopathological relationship. Am. J. Otolaryngol. 7:1986;176-182